60 Degrees Pharmaceuticals
SXTP
3 hedge funds and large institutions have $467K invested in 60 Degrees Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.01% less ownership
Funds ownership: 0.05% → 0.03% (-0.01%)
2% less capital invested
Capital invested by funds: $479K → $467K (-$11.7K)
40% less funds holding
Funds holding: 5 → 3 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$174 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBT
Central Bank & Trust
Lexington,
Kentucky
|
-$80.6K |
| 2 |
Walleye Capital
New York
|
-$26.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16.4K |
| 4 |
VF
Virtu Financial
New York
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CBT
1
Central Bank & Trust
Lexington,
Kentucky
| $361K | -$80.6K | -462 | -24% |
|
|
2
Walleye Capital
New York
| $104K | -$26.5K | -152 | -26% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.14K | +$174 | +1 | +8% |
|
4
Wells Fargo
San Francisco,
California
| $11 | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$16.4K | -92 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$11K | -60 | Closed |
|
SXTP Hedge Fund Activity: Q4 2023 in Review
3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q4 2023, worth a combined $467K — down 2.4% from $479K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SXTP and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $174. The largest seller was Central Bank & Trust, cutting an estimated $80.6K.
- 3 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q4 2023, down from 5 in Q3 2023.
- Funds reported $467K of 60 Degrees Pharmaceuticals stock for Q4 2023, down 2.4% quarter-over-quarter.
- 0 funds opened new 60 Degrees Pharmaceuticals positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q4 2023 was Tower Research Capital (TRC), an estimated $174 added.
- The largest 60 Degrees Pharmaceuticals seller in Q4 2023 was Central Bank & Trust, an estimated $80.6K sold.
Based on aggregated 13F filings for Q4 2023.